A new set of positive/negative selectable markers for mammalian cells

Gene

Volumn 218, Issue 1-2, 1998, Pages 57-61

  Karreman, Christiaan ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Cytidine deaminase; Fusion; In out strategy; Thymidine kinase

Indexed keywords

BLASTICIDIN S; CYTIDINE DEAMINASE; HYGROMYCIN; NEOMYCIN; PUROMYCIN; THYMIDINE KINASE;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; ESCHERICHIA COLI; HERPES SIMPLEX VIRUS; MAMMAL CELL; MARKER GENE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; ARTIFICIAL GENE FUSION; CYTOSINE DEAMINASE; DRUG RESISTANCE; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENETIC MARKERS; HUMANS; MICE; NUCLEOSIDE DEAMINASES; SIMPLEXVIRUS; THYMIDINE KINASE;

ANIMALIA; ESCHERICHIA COLI; HERPES; MAMMALIA; SIMPLEXVIRUS;

EID: 0032544516     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(98)00387-4     Document Type: Article

References (17)

1. Albertini R.J., O'Neill J.P., Nicklas J.A., Heintz N.H., Kelleher P.C. Alterations of the hprt gene in human in vivo-derived 6-thioguanine-resistant T lymphocytes. Nature. 316:1985;369-371.
2. Besnard C., Monthioux E., Jami J. Selection against expression of the Escherichia coli gene gpt in hprt+ mouse teratocarcinoma and hybrid cells. Mol. Cell. Biol. 7:1987;4139-4141.
3. Borrelli E., Heyman R., Hsi M., Evans R.M. Targeting of an inducible toxic phenotype in animal cells. Proc. Natl. Acad. Sci. USA. 85:1988;7572-7576.
4. Graham F.L., van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-467.
5. Karreman S., Hauser H., Karreman C. On the use of double FLP recognition targets (FRTs) in the LTR of retroviruses for the construction of high producer cell lines. Nucleic Acids Res. 24:1996;1616-1624.
6. Karreman, S., 1997. Entwicklung von Strategien zur Expression von Genen in Säugerzellinien durch gerichtete Integration. Thesis TU-Braunschweig, Germany.
7. Karreman C. Fusion PCR, a one step variant of the 'mega-primer' method of mutagenesis. BioTechniques. 24:1998;736-742.
8. Karreman C. New positive/negative selectable markers for mammalian cells on the basis of Blasticidin deaminase-thymidine kinase fusions. Nucleic Acids Res. 26:1998;2508-2510.
9. Kimura M., Takatsuki A., Yamaguchi I. Blasticidin S deaminase gene from Aspergillus terreus (BSD): a new drug resistance gene for transfection of mammalian cells. Biochim. Biophys. Acta. 1219:1994;653-659.
10. Lester S.C., LeVan S.K., Steglich C., DeMars R. Expression of human genes for adenine phosphoribosyltransferase and hypoxanthine-guanine phosphoribosyltransferase after genetic transformation of mouse cells with purified human DNA. Somatic Cell Genet. 6:1980;241-259.
11. Lupton S.D., Brunton L.L., Kalberg V.A., Overell R.W. Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol. Cell. Biol. 11:1991;3374-3378.
12. Mullen C.A., Kilstrup M., Blaese R.M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. Natl. Acad. Sci. USA. 89:1992;33-37.
13. Schwartz F., Maeda N., Smithies O., Hickey R., Edelmann W., Skoultchi A., Kucherlapati R. A dominant positive and negative selectable gene for use in mammalian cells. Proc. Natl. Acad. Sci. USA. 88:1991;10416-10420.
14. Spring K.J., Mattick J.S., Don R.H. Escherichia coli gpt as a positive and negative selectable marker in embryonal stem cells. Biochim. Biophys. Acta. 1218:1994;158-162.
15. Wei K., Huber B.E. Cytosine deaminase gene as a positive selection marker. J. Biol. Chem. 271:1996;3812-3816.
16. Wigler M., Silverstein S., Lee L.S., Pellicer A., Cheng Yc., Axel R. Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell. 11:1977;223-232.
17. Zeng M., Lapeyre J.-M. Cloning strategies using a third irrelevant enzyme site (TIES) to overcome certain cloning problems. BioTechniques. 20:1996;56-60.